PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “MENIERE'S DISEASE”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 847 records · Page 47Linked to original sources

Shunt surgery in Meniere's disease: a follow-up report.

Between December 1969 and May 1986, 140 patients were treated for Menière's disease using the endolymphatic sac subarachnoid shunt. The technique and results are contrasted with an earlier report. The surgical technique described includes modifications of the originally described procedure. A microcomputer was used for the storage and manipulation of data based upon 1972 Academy criteria. Control of vertigo was accomplished in 83% of patients; 51% of patients were graded class A or B, according to the 1972 Academy criteria. No serious complications occurred. Problems included the potential for serious complications, the lack of specific criteria for patient selection, and the continued deterioration of hearing with the passage of time. Comparison of data with those presented in 1973 indicates a lower overall success rate, but continued success in the management of vertigo and imbalance. The endolymphatic sac subarachnoid shunt is worthy of consideration in the management of Menière's disease when surgery is indicated and retention of hearing is desirable.

Adult↗

[An association study of histocompatibility leukocyte antigen-class II with Meniere's disease].

OBJECTIVE: To investigate the relation between histocompatibility leukocyte antigen (HLA)-class II DRB1 and Meniére's disease in Chinese. METHODS: Polymerase chain reaction-sequence specific primers (PCR-SSP) technique was used. HLA-class II allele distribution were measured in 60 patients with Meniére's disease, in comparison with those in 85 normal population. RESULTS: The results showed that the frequency of DRB1*09 allele was significantly lower in Meniére's disease patients than in those of controls (relative risk = 0.17, P < 0.01). CONCLUSION: HLA-DRB1*09 of the patients with Meniére's disease was significant low. It implied that DRB1*09 may be a protective gene for Meniére's disease.

Adolescent↗

Round window ultrasonic irradiation for Meniere's disease with ENG monitoring.

Utrasonic irradiation of the labyrinth via the round window is effective in controlling otological vertigo. This method of surgical management for incapacitating vertigo is presented with demonstrative intraoperative electronystagmograms and irradiated cat neuro-epithelium. Such data suggest that more intense irradiation doses than previously reported should be applied to effectively destroy the diseased labyrinthine end organs. Precise end points of destructive irradiation are defined by characteristic intraoperative electronystagmograms. The authors suggest this is an ideal procedure when the situation of an unaffected cochlea, coexisting with a diseased labyrinth, requires a minimally invasive, destructive procedure which preserves hearing while eradicating vertigo.

Ear, Inner↗

[Noninvasive evaluation of intracochlear pressure. II. Study findings in patients with Meniere's disease, fluctuating deep tone hearing and peripheral vestibular vertigo].

The tympanic membrane displacement technique (TMD) is aimed at evaluating intracochlear and intracranial pressure changes non-invasively. Therefore, the present paper describes the findings in patients with Ménière's disease where an increase in volume of the endolymphatic spaces is discussed. It should be investigated to which extent a change in the intracochlear pressure corresponds to different stages of the disease. It could be described that the intracochlear pressure does change over a certain period of persisting Ménière's, but that there is no extensive increase in intracochlear pressure between the attacks. The glycerol test as well as the acute attack (case report on one patient) are, however, characterised by distinct patterns. The same holds true for the late-stage Ménière's. It could be demonstrated that the functional patency of the cochlear aquaeduct in patients with long-term Ménière's history is reduced. This finding is surprising and should be investigated further. In essence, the TMD technique enables to better characterise Ménière patients, but it should not be a tool of routine diagnosis of the disease. In some audiological patients, it can also be beneficially applied (10).

Adolescent↗

[Variability of N in Meniere's disease].

Intratympanic treatment of incapacitating vertigo in Menière's disease has become a first option treatment for most otolaryngologists nowadays. Reporting their results following adequate minimum follow-up and under the same criteria is as important as to clearly state the indications that have been settled, through adequate handicap psychometric tests. Furthermore, when results are reported, knowing the total number of patients (N) with a diagnosis of Menière's disease is essential to evaluate such results in those treated patients, bearing in mind that most Menière's patients do well with medical treatment as well.

Administration, Topical↗

[Multifrequency tympanometry in Meniere's disease: preliminary results].

Tympanometry with 220 Hz probe tone mainly measures compliance related components of the middle ear. Only higher frequency probe tones provide information on mass related components. In order to study the behavior of the mass related components in endolymphatic hydrops, the Authors tested 15 Ménière's disease patients and 10 healthy subjects using multifrequency tympanometry. In both groups tympanometry with 220 and 678 Hz probe tone was employed to evaluate resonance frequency. The presence of a "camel hump" ([symbol: see text]) pattern obtained with the 678 Hz probe tone test indicated an elastic tympano-ossicular system (low point of middle ear resonance); the presence of an inverted "V" ([symbol: see text]) pattern showed a more rigid system (high point of middle ear resonance). In Ménière's disease carriers multifrequency tympanometry revealed 21 ears (70%) with a resonance frequency higher and 6 (20%) lower than 678 Hz. Three patterns (10%) were not classifiable. In the healthy group resonance frequency resulted lower than 678 Hz in 23 ears (57.5%); in 13 ears higher (32.5%). Four patterns (10%) were not classifiable. In Ménière's disease carriers the tympanometric patterns found with 678 Hz probe tone indicated the presence of a more rigid tympano-ossicular system.

Acoustic Impedance Tests↗

The ultrastructure of the endolymphatic sac in Meniere's disease.

Biopsies of the endolymphatic sac were performed in 6 patients undergoing endolymphatic sac decompression and/or drainage procedures. Electron microscopy revealed extensive subendothelial fibrosis with loss of vascularity, heavy deposition of collagen and flattening of luminal cells. In patients with long-standing disease, complete obliteration of the endolymphatic sac lumen appeared to occur. There was poor correlation between the surgeon's ability to identify the lumen of the endolymphatic sac and its presence in the biopsy specimen.

Collagen↗

Intratympanic corticosteroids for Meniere's disease and vertigo.

Hearing loss can be caused by acoustic trauma, aging, ototoxic medications, and various other causes. At the cellular level hearing loss seems to be mediated by reactive oxygen species and ultimately through the activation of apoptotic mechanisms. This article explains the cellular and molecular mechanisms of hearing loss and presents medications that could be used in the intratympanic treatment of hearing loss.

Administration, Topical↗

Glycerin and urea tests in Meniere's disease. A multifactorial analysis using a quantification method.

By using the quantification method for multidimensional qualitative data, 13 variables were analyzed. The younger the patient, the stronger was the correlation between age and positive glycerin and urea tests. At ages over 50 years no correlation with positive test results was found. The longer the duration of disease, the stronger was the correlation between this duration and a positive urea test. The glycerin test showed no correlation with the duration of the disease. Hearing losses of 40 to 69 dB. were correlated with both a positive glycerin test and a positive urea test. Greater hearing losses were correlated only to a positive glycerin test. Hearing losses less than 39 dB. were not correlated with positive results in either the glycerin or the urea test.

Adult↗

Histopathologic findings in surgical specimens of endolymphatic sac in Meniere's disease.

Two types of abnormality in the endolymphatic sac acquired at shunt surgery are presented. One was deep brown pigmentation in the subepithelial connective tissue. The pigment did not react to Prussian blue, thus ruling out hemosiderin. The other, in seven out of eight specimens, was the perisaccular fibrosis. The fibrotic foci in four cases were assumed, from the findings under ordinary illumination and polarized light microscopy, to be reorganized scar tissue.

Atrophy↗

[Meniere's disease. The clinical effect of gentamicin treatment].

In patients with Menière's disease attacks of vertigo can be invalidating. We have tested the effect of instillation of gentamycin in the middle ear to minimize or stop the attacks of vertigo. The results of a prospective investigation of 14 patients with Menière's disease treated with gentamycin in the period from 1993 to 1996 are presented. The patients were followed up to 53 months after the treatment and a telephone follow-up was performed. At the last follow-up nine out of 12 patients were free of attacks of vertigo. Two improved and one patient was unchanged. In two patients deafness developed in the treated ear, in the other patients the hearing was unchanged measured by speech reception threshold and discrimination loss. It is concluded that treatment of patients with Menière's disease by instillation of gentamycin into the middle ear does have a therapeutic effect. The treatment is simple and the effect of treatment is equal to other types of treatments. The risk of deafness in the treated ears stresses the importance of giving the patient sufficient information before treatment.

Administration, Topical↗

Indomethacin blocks acute audiologic effects of furosemide in Meniere's disease.

The acute audiologic effects of glycerin and furosemide were measured with and without indomethacin pretreatment in two patients. The positive effects of glycerin were not blocked by indomethacin. The positive effect of furosemide on discrimination score was blocked by indomethacin. The concomitant rise in plasma renin level after furosemide was also blocked by indomethacin. A role for prostaglandins in inner ear fluid dynamics is suggested by this study. It appears that glycerin and furosemide affect inner ear fluid dynamics by different mechanisms.

Aged↗